ECML - ETF AI Analysis

Compare

Top Page

Euclidean Fundamental Value ETF (ECML)

Rating:71Outperform

Price Target:

$36.00

The Euclidean Fundamental Value ETF (ECML) has a solid overall rating, reflecting a balanced mix of strong-performing holdings and a few weaker contributors. Notable strengths include Newmont Mining, which benefits from robust cash flow generation and strategic initiatives, and Mueller Industries, which demonstrates excellent financial health and profitability. However, holdings like Oshkosh and Perdoceo Education show weaker technical momentum and mixed earnings sentiment, slightly tempering the fund's overall rating. A key risk factor is the ETF's exposure to stocks with bearish or neutral technical trends, which could impact short-term performance.

Positive Factors

Strong Top Holdings

Several of the largest positions, such as PTC Therapeutics and Oshkosh, have delivered strong year-to-date gains, supporting the fund’s overall performance.

Sector Diversification

The ETF is spread across multiple sectors, including Consumer Cyclical, Health Care, and Industrials, reducing reliance on any single industry.

Healthy Performance Trend

The fund has shown steady growth over the past three months, indicating positive momentum despite short-term fluctuations.

Negative Factors

High Expense Ratio

The ETF charges a relatively high expense ratio compared to many other funds, which can eat into investor returns over time.

Geographic Concentration

With nearly all assets focused in the U.S., the fund lacks meaningful exposure to international markets, limiting global diversification.

Short-Term Underperformance

The ETF experienced a decline in the past month, which may concern investors looking for consistent returns.

ECML vs. SPDR S&P 500 ETF (SPY)

AUM127.06M

RegionNorth America

Expense Ratio0.95%

Beta0.84

IssuerEuclidean

Inception DateMay 18, 2023

Dividend Yield0.96%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume896

30 Day Avg. Volume7,342

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

36.81

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering65

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

ECML Summary

The Euclidean Fundamental Value ETF (ECML) is designed for investors who want to focus on value investing across the entire market. It includes companies that are financially strong and have growth potential but are trading at lower prices than their true worth. Some of its top holdings include well-known names like Fox and Altria Group. This ETF is a good option for those looking to diversify their portfolio and invest in undervalued companies with the potential for long-term growth. However, new investors should be aware that the ETF’s performance depends on the overall market and the success of the value investing strategy, which can sometimes underperform during periods of rapid market growth.

How much will it cost me?The Euclidean Fundamental Value ETF (ECML) has an expense ratio of 0.95%, meaning you’ll pay $9.50 per year for every $1,000 invested. This is higher than average because it is actively managed, requiring more research and analysis to select investments compared to passively managed ETFs that track an index.

What would affect this ETF?The Euclidean Fundamental Value ETF (ECML) could benefit from a strong U.S. economy, especially in sectors like Consumer Cyclical and Health Care, which make up a significant portion of its portfolio. However, rising interest rates or economic slowdowns might negatively impact consumer spending and corporate growth, particularly in cyclical industries. Regulatory changes or shifts in energy and materials markets could also influence performance, given the ETF's exposure to these sectors.

ECML Top 10 Holdings

The Euclidean Fundamental Value ETF leans heavily into consumer cyclical and health care sectors, with names like Dillard’s and PTC Therapeutics driving recent gains thanks to strong profitability and strategic advancements. Newmont Mining has also been a bright spot, benefiting from robust cash flow and operational momentum. However, Fox and Group 1 Automotive have been lagging, with bearish technical signals and moderate leverage concerns holding back performance. With a focus on U.S.-based companies, the fund’s positioning reflects a value-driven approach, but its sector concentration may leave it vulnerable to cyclical swings.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
HSII	Heidrick & Struggles	2.92%	$3.71M	$1.22B	23.58%	75 Outperform
MLI	Mueller Industries	2.80%	$3.55M	$11.89B	13.44%	78 Outperform
FOXA	Fox	2.74%	$3.48M	$27.76B	47.91%	77 Outperform
DDS	Dillard's	2.64%	$3.35M	$9.47B	50.58%	73 Outperform
MD	Pediatrix Medical Group	2.51%	$3.19M	$1.88B	39.15%	76 Outperform
PTCT	PTC Therapeutics	2.35%	$2.98M	$5.76B	62.10%	74 Outperform
PRDO	Perdoceo Education	2.24%	$2.85M	$1.94B	20.86%	73 Outperform
LAUR	Laureate Education	2.21%	$2.81M	$4.48B	61.73%	73 Outperform
NEM	Newmont Mining	2.14%	$2.73M	$91.00B	85.15%	81 Outperform
OSK	Oshkosh	2.14%	$2.72M	$7.68B	8.80%	71 Outperform

ECML Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

33.12

Negative

100DMA

32.35

Positive

200DMA

31.48

Positive

Market Momentum

MACD

-0.20

Positive

RSI

42.36

Neutral

STOCH

22.61

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ECML, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 32.67, equal to the 50-day MA of 33.12, and equal to the 200-day MA of 31.48, indicating a neutral trend. The MACD of -0.20 indicates Positive momentum. The RSI at 42.36 is Neutral, neither overbought nor oversold. The STOCH value of 22.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ECML.

ECML Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
ECML	―	―	$127.06M	0.95%	71 Outperform
VFVA	―	―	$693.73M	0.13%	67 Neutral
LSVD	―	―	$531.44M	0.40%	75 Outperform
QVAL	―	―	$406.39M	0.29%	72 Outperform
AIVL	―	―	$374.03M	0.38%	71 Outperform
BUSA	―	―	$256.49M	0.60%	70 Neutral

Performance Comparison

ECML

Euclidean Fundamental Value ETF

32.35

-3.04

-8.59%

VFVA

Vanguard U.S. Value Factor ETF

―

LSVD

LSV Disciplined Value ETF

―

QVAL

Alpha Architect U.S. Quantitative Value ETF

―

AIVL

WisdomTree U.S. AI Enhanced Value Fund

―

BUSA

Brandes U.S. Value ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents